HOME >> MEDICINE >> NEWS
Within six months, one in three patients fail to take medications as prescribed

CHICAGO Therapy that includes medications to reduce high blood pressure and to lower lipid levels can reduce risk for heart disease, but within six months, more than a third of patients fail to take one or both medications as prescribed, according to a study in the May 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Patients with both high blood pressure and dyslipidemia (high lipid levels), are at substantially greater risk of coronary heart disease (CHD) events, such as heart attack, than those with either condition alone, according to background information in the article. The current study was designed to study how well patients with both conditions adhere to a drug regimen including both anti-hypertensive (AH, blood pressure lowering) and lipid-lowering (LL) medications.

Richard H. Chapman, Ph.D., of ValueMedics Research, L.L.C., Arlington, Va., and colleagues examined the database from a managed care organization to identify patients who had been prescribed both anti-hypertensive and lipid-lowering medications within a period of 90 days between January 1, 1997, and January 30, 2001. Adherence to concomitant therapy (taking both medications) was established at three, six and 12 months following treatment start on the basis of prescriptions filled. Patients were considered to be taking their drugs as prescribed if they had filled prescriptions sufficient to cover at least 80 percent of days of both classes of medications.

A total of 8,406 patients were followed for an average of 12.9 months. The percentage of patients adhering to both anti-hypertensive and lipid-lowering declined sharply over the course of the study, with 44.7 percent maintaining their treatment regimen at three months, 35.9 percent at six months and 35.8 percent at twelve months. At each time interval, an additional 25.3 to 29.6 percent were taking one, but not both, drugs as prescribed.

The strongest predictor of taking both m
'"/>

Contact: Richard H. Chapman, Ph.D.
rick.chapman@valuemedics.com
JAMA and Archives Journals
23-May-2005


Page: 1 2

Related medicine news :

1. Infants, as early as six months, do see errors in arithmetic
2. Study finds three-quarters of women are households chief cook and food shopper
3. Researchers use novel three-dimensional imaging technique
4. Free drug samples influence prescribing, say one in three doctors
5. Top NIH prize goes to three pioneering Stanford scientists
6. No advantage for four-drug antiretroviral regimen vs. three-drug for initial treatment of HIV-1
7. Hispanic and African American adults are uninsured at rates 1 1/2 to three times higher than whites
8. Combination of three new, high-powered MRI systems at PENN is a first in the US
9. Compulsion to smoke after just one cigarette can lie dormant for more than three years
10. Therapeutic communities: A three country comparison
11. Bold three-stage brain operation for intractable seizures appears promising

Post Your Comments:
(Date:5/21/2013)... 22, 2013 Spring is the perfect ... farmers' markets filled with whole foods to weather perfect ... of the season the nutrition experts at Brilliant Nutrition ... to miss. , 1. Eating Locally, With the abundance ... to linger and explore, spring is a great time ...
(Date:5/21/2013)... Feed additives have now become an essential ... Most of the feed additives are used in micro ... powders. There are variety of feed additives available that ... the type of animal and feed. Nutritional feed additives ... nutrition to the animal in order to gain lean ...
(Date:5/21/2013)... May 21, 2013 Daily Gossip Magazine published ... their readers and keep people informed on the latest weight ... reporters have prepared an in-depth review of Kyle ... useful for readers who want to lose weight or stay ... Daily Gossip the program was created by a popular fitness ...
(Date:5/21/2013)... Diego, CA (PRWEB) May 21, 2013 ... adding materials showing how to use 17 DISC applications ... is a natural progression. , The July 25 ... feature the top 17 ways of applying DISC. The ... DISC certified graduates. The user-friendly DISC training ...
(Date:5/21/2013)... 21, 2013) Prostaglandin analogues (PGAs), drugs which lower ... for people with glaucoma, but their use is not ... vision, dryness, changes in eye color and other side ... drugs also cause upper and lower eyelid drooping and ... are described in PLOS ONE . , Researchers ...
Breaking Medicine News(10 mins):Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4Health News:Customized Fat Loss Plan Review and Diet Secrets Revealed By Daily Gossip Magazine 2Health News:DISCcert Offers 17 Applications in Coming DISC Certification 2Health News:DISCcert Offers 17 Applications in Coming DISC Certification 3Health News:DISCcert Offers 17 Applications in Coming DISC Certification 4Health News:Glaucoma drug can cause droopy eyelids 2
(Date:5/21/2013)... , May 21, 2013  Armada Health ... of the new Armada corporate website ( www.armadahealthcare.com ... communicate Armada,s unique and first-to-market services and its ... focused on the specialty pharmacy industry. ... of the Armada business model in delivering an ...
(Date:5/21/2013)... 21, 2013  Cephasonics, a technology-innovation leader ... the introduction of the cQuest Ultrasound SDK™ ... with all cQuest Ultrasound™ hardware platforms. Cephasonics ... this new capability, at Hospitalar 2013 held ... from May 21-24.  Cephasonics is located ...
(Date:5/21/2013)... , May 21, 2013 Hurel Corporation ("Hurel"), ... microfluidic cell-based assay platforms, today announced the appointment of ... to the Company,s Board of Directors. Dr. MacDonald is ... the Schering-Plough Research Institute ("SPRI"), which was the pharmaceutical ... by Merck & Co. in 2009. Over ...
Breaking Medicine Technology:Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
Cached News: